About AnnJi Pharmaceutical Co. Ltd
Dedicated to New Drug Development in Dermatology & Neurology
Meet Our Board Members
Wendy Huang, Ph.D.
Chair & CEO
AnnJi Pharmaceutical
- Ph.D. in Toxicology, North Carolina State University
- Forty years pharmaceutical career across multiple therapeutic areas, medical devices and cosmetic products.
- Held R&D Leadership and executive positions in multinational companies, including GSK, Stiefel Labs, Connetics Corp., Dermik Laboratories, and Sanofi-Aventis.
- A strong track record in global product development and organizational development.
- Lead and contributed to more than 10 market authorizations of new drug products and medical devices.
Jerome Shen, Ph.D.
General Partner/Head of Life Science Investments
Taiwania Capital
- Ph.D. in Chemical Engineering at the University of Wisconsin, Madison
- The President and co-founder of Allgenesis Biotherapeutics Inc., a new drug development company addressing the unmet medical needs in the ophthalmology areas since 2014.
- Before Allgenesis, he was an executive with venture capital firms for 20 years; focusing on investment in the life science and biotech/pharmaceutical industry.
- He also took the leading roles in several biotech start-ups, responsible for corporate development and strategic initiatives and planning.
- The Secretary-General of Taiwan Biotech Association, a non-profit organization, from 2005 to 2008.
Calvin Tsai
Director of the Board / CEO of Orient EuroPharma CO., Ltd.
- Accounting, University of California. Riverside, USA
- Director of the Board / CEO of Orient Pharma CO., Ltd.
- Chairman of OP NanoPharma Co., Ltd.
- Legal representative person of Babecare Co., Ltd.
- Director of the Board of Hung Lu Foundation
- Independent director of Simple Mart Retail Co., Ltd.
- Pierre Fabre Medicament, UK – Assistant Product Manager
- Deloitte & Touché – Auditor II
- Elan Pharmaceutical Co., San Diego – Financial Analyst / Financial Liaison of Sales and Marketing Division
Willy Huang
Project Vice General Manager
Fubon Financial Holding Venture Capital
- M.S. in Institute of Microbiology & Immunology, National Yang Ming Chiao Tung University, Taiwan
- Project Vice General Manager, Fubon Financial Holding Venture Capital
- Investment Manager, CDIB BIOSCIENCE VENTURE MANAGEMENT
- Manager, China Chemical & Pharmaceutical Co., Ltd.(BVI), INC.
- Sales Representative, Novartis Taiwan Co Ltd.
Dean Chuang
Director of President International Development Corp.
- M.S. in Genetics, National Yang-Ming University
- Over ten years of experience in the biotech/healthcare investments in Taiwan, US, and China. Deeply involved in several licensing deals and M&A transactions.
Yu-Hui Su Ph.D.
Independent Board Director
- Ph.D. in Business Administration, National Taiwan University
- Distinguished Professor in the Department of Accounting of Soochow University
- US Fulbright Visiting Scholar Award in 2000
- Certified Public Accountant of ROC (CPA)
- International Internal Auditor (CIA)
- Certification in Control Self-Assessment (CCSA)
- Used to be Supervisor of Chinese Petroleum Corporation, Mega Bank, Bank of Kaohsiung, Independent Director of TWi Pharmaceuticals, and Secretary-General of Taiwan Accounting Association.
Alex Chang
Independent Board Director
- MBA from University of Chicago
- More than 30 years of experience in the global pharmaceutical industry across the U.S., Asia, Middle East and Africa.
- Senior vice president at Ferring Pharmaceuticals
- President and Head of Asia Cluster at Novartis Taiwan
- Vice President of Sales and Marketing at for Xian Janssen, a subsidiary of Johnson & Johnson in China
- Managing director of Janssen Taiwan
Jaw-Jou Kang Ph.D.
Independent Board Director
- Ph.D. in Chemistry, University of California, San Diego
- Rich experience in biotechnology and drug safety regulation
- Professor in the Institute of Food Safety and Health Risk Assessment at National Yang-Ming Chiao Tung University
- President of the Pharmaceutical Society of Taiwan
- Director of the Taiwan General Office of Food Safety
- Director General of the Taiwan FDA
Jing-Ping Liou Ph.D.
Independent Board Director
- Ph.D. in Institute of Pharmacy, School of Medicine, National Taiwan University
- Dean of Taipei Medical University College of Pharmacy
- Vice Dean of Taipei Medical University College of Pharmacy
Taiwan’s leading new drug developer in dermatology & neurology
Translation and development of new chemical entities from lead optimization, candidate selection to clinical proof-of-concept
